Aug. 14 at 12:15 AM
$EMBC
Why is this stock easily still going to return a 100% in 6 months?
* Analysts dropped projected price due to the expected continued decline in domestic earnings and lack of market share for injectables (This was proven wrong through new signed contracts increased domestic earnings and identifying new revenue streams)
* Sales, spending, and debt were worse coming into and through Q2 when the stock price exceeded 9 in 2026.
* EPS in Q3 exceeded 2025 Q4 when stock prices pushed past 12 a share.
* Q1 represented the highest hedge fund acquisitions in the last 2 years.
* EMBC repurchased approximately 2.7 million shares in Q3 and should be expected to purchase approximately 1.6 million in Q4.
* internal purchasing of shares shows a solid belief in longevity and earnings.
Expectations that more contracts will be signed, Ownen Mumford will be delivering a cutting edge injectable, a move to GLP-1 contracts, an anticipated higher EPS in the 4th less available stocks in circulation.
